Biotech Investor, Former Scientist, M.D., Tweets since October 2019
Joined December 2013
- Tweets 4,344
- Following 91
- Followers 3,352
- Likes 2,533
100 Photos and videos
Pinned Tweet
10 Nov 2022
Everyone who sees these photos and is reasonably healthy should pause for a moment and be somewhat humbled and grateful. Often in everyday life you forget how relatively well you are doing and get angry about trivial things and do not enjoy the here and now.
7
2
60
1
5
213
There is currently a lot of buzz surrounding oral peptides as treatments for immune-related diseases. In this context, it is worth noting #Peptidream’s IL-17A-binding peptide, which has yet to attract the attention of international investors.
$PPTDF
patents.google.com/patent/US…
1
429
Outstanding results from $ZYME's anti-FRα ADC ZW191.
78.6% cORR in FRα-pos platinum-resistant ovarian cancer patients and 47.4% in FRα-neg patients across all (!) dose levels studied.
DCR 100% (85%)
mPFS (all patients) 7.6 months
ir.zymeworks.com/news-releas…
1
7
706
German Biotech retweeted
Jun 12
3/1: "four to five weeks"
3/9: "very soon"
3/16: "won't be long"
3/23: "very good and productive conversations"
3/26: talks to end the war are “going very well"
3/29: "I think we'll make a deal with them, pretty sure"
4/1: “very shortly”
4/6: "They’ve made a proposal, and it’s a significant proposal."
4/8: ""A big day for World Peace!"
5/18: "we’ve had very big discussions with Iran"
5/23: "will be announced shortly."
6/1: "rapid pace"
6/11: "next few days"
60
330
1,482
126,233
Jun 11
#Peptidream $PPTDF has initiated clinical development of its CLDN18.2 radiopeptide conjugate for the treatment of GEA.
contents.xj-storage.jp/xcont…
1
1
811
Jun 11
Curium and #PeptiDream $PPTDF announce completion of patient dosing in Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer.
finance.yahoo.com/sectors/he…
691
The stock markets are likely to suffer in the near future from numerous massive IPOs, which will drain a lot of liquidity from the market. Recently, geopolitical risks and inflationary threats have also been overlooked. I will definitely be keeping an eye on the $VIX.
1
5
931
It would be more accurate to speak of geopolitical upheavals rather than risks.
3
531
What amazes me about $ABVX is this: there are a surprising number of users on X who, like cult followers, paint best-case scenarios and brush aside any doubts; somehow, there’s a complete lack of detachment and objectivity. I find this kind of thing alarming.
/1
14
1
32
8,253
A psychological study should be conducted to investigate how such strange states of mind can arise.
/2
1
1,416
I'll be watching the webcast tomorrow. #Peptidream $PPTDF is one of my favorites in the biotech sector. At the current price level, I find them very interesting.
🇺🇸Our President, Patrick Reid, will participate in a fireside chat at the Jefferies Global Healthcare Conference at 5:30pm on June 3 in New York. The live webcast of the ‘Fireside Chat’ will be available here.
event.summitcast.com/view/Ng…
1
1
2,038
All in all, a very superficial event. It seems to be aimed at an audience that has never really looked into #peptidream $PPTDF. What a waste of time - I’m not going to listen to the rest of the presentation.
1
556
$ABVX
The increased incidence of NMS cancers among patients undergoing long-term obefazimod therapy is surprising and puzzling. Normally, the induction of mir-124 has an inhibitory effect on the development of cutaneous tumors (see below).
/1
sciencedirect.com/science/ar…
1
12
4,567
be associated with obefazimod $ABVX) would not be a reason to refrain from treatment with obefazimod.
Overall, the results of the ABTECT Maintenance Trial look promising.
/4
1
1
8
1,620
$ABVX
On the topic of “mir-124 and tumors,” here is an additional figure from Cancer Medicine 2019, 8, 5638-5650.
/5
1
6
990
$ABVX
I do not share the extreme optimism expressed in yesterday’s webcast regarding obefazimod for Crohn’s disease. There are several scientific studies that suggest that the upregulation of miR-124 might worsen Crohn's symptoms. I pointed that out six years ago.
21 Jan 2020
2
19
7,035
$ABVX
In light of recent events: I discussed the tumor-protective effects of mir-124 here six years ago. The literature cited at that time remains relevant today and has since been confirmed by numerous recent studies.
30 Jan 2020
$ABVX
Additional indication possibilities for #ABX464 in oncology?
miR-124 serves as a tumor suppressor!
free download -->
journals.plos.org/plosone/ar…
jcancer.org/v09p3006.htm
1
14
3,335